|
⚲
|
| Keyboard |
| Nuerge William A
✚
|
|
|---|---|
| CIK # | 0001540039 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001540039] | |
| 4 | [0001540039] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nuerge William A | |
| Supernus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2017-06-13 | Grant | 6,036 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2017-02-24 | Grant | 7,905 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2016-03-01 | Grant | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2015-03-03 | Grant | 20,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2014-01-21 | Grant | 7,457 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2013-02-05 | Grant | 8,722 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2012-05-04 | Buy | 15,000 | $5.00 | 75,000 |